Treatment of syringomyelia using uncultured umbilical cord mesenchymal stem cells: A case report and review of literature

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

BACKGROUND Syringomyelia is a disease caused by the formation of a cavity inside the spinal cord and is accompanied by such symptoms as pain, paresthesia, and urination and defecation disorders, and in severe cases causes various paralyses. Currently, there are only surgical methods for the treatment of syringomyelia, but these methods carry the possibility of failure, recurrence, and side effects. CASE SUMMARY The patient was a 59-year-old woman who suffered from pain due to syringomyelia. For treatment, the patient received transplant of uncultured umbilical cord-derived mesenchymal stem cells. As intended, the patient's pain was relieved after treatment. Interestingly, an additional benefit was found in that the size of the cavity also decreased. After 2 years from the last treatment, the patient's cavity had almost completely disappeared and her syringomyelia was deemed cured. CONCLUSION Using uncultured umbilical cord-derived mesenchymal stem cells may be a new treatment alternative for syringomyelia

Cite

CITATION STYLE

APA

Ahn, H., Lee, S. Y., Jung, W. J., & Lee, K. H. (2022). Treatment of syringomyelia using uncultured umbilical cord mesenchymal stem cells: A case report and review of literature. World Journal of Stem Cells, 14(4), 303–309. https://doi.org/10.4252/wjsc.v14.i4.303

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free